GENESIS VECTOR MANUFACTURING SOLUTIONS
LIVE

Serial Number

97705178

Owner

CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC

Attorney

Joshua M. Gerben, Esq.

First Use Date

Jan 22, 2024

Filing Date

Dec 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GENESIS VECTOR MANUFACTURING SOLUTIONS Trademark

Serial Number: 97705178 • Registration: 7393135

GENESIS VECTOR MANUFACTURING SOLUTIONS is a trademark filed by CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC on December 6, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC (19 trademarks)

411 SWEDELAND ROAD
KING OF PRUSSIA, PA 19406

Entity Type: 16

Trademark Details

Filing Date

December 6, 2022

Registration Date

May 21, 2024

First Use Anywhere

January 22, 2024

First Use in Commerce

January 22, 2024

Published for Opposition

October 31, 2023

Goods & Services

Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals, plasmid DNA production; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting

Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy acceleration, vector genome copy titers, droplet digital polymerase chain reaction (PCR) and digital polymerase chain reaction (PCR), mass spectrometry, capsid characterization, bioassays, plasmid DNA, and analytics testing in the field of genes and gene therapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 21, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 21, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 18, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 17, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 29, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 29, 2024 AITU
USE AMENDMENT FILED
Feb 6, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 6, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2022 NWOS
NEW APPLICATION ENTERED
Dec 9, 2022 NWAP